# Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma

> **NCT03097328** · PHASE2 · COMPLETED · sponsor: **Bradley A. McGregor, MD** · enrollment: 39 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** TAK-228

## Key facts

- **NCT ID:** NCT03097328
- **Lead sponsor:** Bradley A. McGregor, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2021-07-20
- **Final completion:** 2024-04-24
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2024-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03097328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03097328, "Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03097328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*